BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 26030120)

  • 21. Transapical aortic valve implantation - an Australian experience.
    Seco M; Martinez G; Bannon PG; Cartwright BL; Adams M; Ng M; Wilson MK; Vallely MP
    Heart Lung Circ; 2014 May; 23(5):462-8. PubMed ID: 24315653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The JUPITER registry: One-year outcomes of transapical aortic valve implantation using a second generation transcatheter heart valve for aortic regurgitation.
    Silaschi M; Conradi L; Wendler O; Schlingloff F; Kappert U; Rastan AJ; Baumbach H; Holzhey D; Eichinger W; Bader R; Treede H
    Catheter Cardiovasc Interv; 2018 Jun; 91(7):1345-1351. PubMed ID: 29171730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transapical minimally invasive aortic valve implantation and conventional aortic valve replacement in octogenarians.
    Strauch JT; Scherner M; Haldenwang PL; Madershahian N; Pfister R; Kuhn EW; Liakopoulos OJ; Wippermann J; Wahlers T
    Thorac Cardiovasc Surg; 2012 Jul; 60(5):335-42. PubMed ID: 22547302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transaortic transcatheter aortic valve implantation: Results of the Polish arm of the ROUTE registry.
    Jagielak D; Bramlage P; Pawlaczyk R; Brzeziński M; Fijałkowski M; Łaskawski G; Ciećwierz D; Rogowski J; Kozaryn R
    Cardiol J; 2015; 22(6):651-6. PubMed ID: 26202653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcatheter aortic valve implantation using anatomically oriented, marrow stromal cell-based, stented, tissue-engineered heart valves: technical considerations and implications for translational cell-based heart valve concepts.
    Emmert MY; Weber B; Behr L; Sammut S; Frauenfelder T; Wolint P; Scherman J; Bettex D; Grünenfelder J; Falk V; Hoerstrup SP
    Eur J Cardiothorac Surg; 2014 Jan; 45(1):61-8. PubMed ID: 23657551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
    Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving outcomes: case-matched comparison of novel second-generation versus first-generation self-expandable transcatheter heart valves.
    Schaefer A; Treede H; Schoen G; Deuschl F; Schofer N; Schneeberger Y; Blankenberg S; Reichenspurner H; Schaefer U; Conradi L
    Eur J Cardiothorac Surg; 2016 Aug; 50(2):368-73. PubMed ID: 26888463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transapical transcatheter aortic valve implantation using a new second-generation TAVI system - J-Valve™ for high-risk patients with aortic valve diseases: Initial results with 90-day follow-up.
    Zhu D; Chen Y; Guo Y; Hu J; Zhang J; Wei X; Tang H; Shi Y
    Int J Cardiol; 2015 Nov; 199():155-62. PubMed ID: 26197402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis.
    Ussia GP; Barbanti M; Petronio AS; Tarantini G; Ettori F; Colombo A; Violini R; Ramondo A; Santoro G; Klugmann S; Bedogni F; Maisano F; Marzocchi A; Poli A; De Carlo M; Napodano M; Fiorina C; De Marco F; Antoniucci D; de Cillis E; Capodanno D; Tamburino C;
    Eur Heart J; 2012 Apr; 33(8):969-76. PubMed ID: 22240494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thirty-day Outcome Following CoreValve Evolut R Transcatheter Aortic Valve Implantation: An All-comers Prospective Study.
    Perrin N; Roffi M; Frei A; Hachulla AL; Ellenberger C; Müller H; Cikirikcioglu M; Licker M; Noble S
    Rev Esp Cardiol (Engl Ed); 2017 Sep; 70(9):713-719. PubMed ID: 28034684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction.
    Cheung A; Webb JG; Barbanti M; Freeman M; Binder RK; Thompson C; Wood DA; Ye J
    J Am Coll Cardiol; 2013 Apr; 61(17):1759-66. PubMed ID: 23500301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transapical aortic valve implantation: incidence and predictors of paravalvular leakage and transvalvular regurgitation in a series of 358 patients.
    Unbehaun A; Pasic M; Dreysse S; Drews T; Kukucka M; Mladenow A; Ivanitskaja-Kühn E; Hetzer R; Buz S
    J Am Coll Cardiol; 2012 Jan; 59(3):211-21. PubMed ID: 22240125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Outcomes After Transapical and Transfemoral Transcatheter Aortic Valve Insertion: An Evolving Experience.
    Murashita T; Greason KL; Pochettino A; Sandhu GS; Nkomo VT; Bresnahan JF; Reeder GS; Holmes DR; Rihal CS; Mathew V
    Ann Thorac Surg; 2016 Jul; 102(1):56-61. PubMed ID: 27112646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Introduction of an interdisciplinary heart team-based transcatheter aortic valve implantation programme: short and mid-term outcomes.
    Martínez GJ; Seco M; Jaijee SK; Adams MR; Cartwright BL; Forrest P; Celermajer DS; Vallely MP; Wilson MK; Ng MK
    Intern Med J; 2014 Sep; 44(9):876-83. PubMed ID: 24965193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcatheter aortic valve implantation in very high-risk patients with EuroSCORE of more than 40%.
    Drews T; Pasic M; Buz S; d'Ancona G; Dreysse S; Kukucka M; Mladenow A; Hetzer R; Unbehaun A
    Ann Thorac Surg; 2013 Jan; 95(1):85-93. PubMed ID: 23141527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term clinical outcomes among patients undergoing transcatheter aortic valve implantation in Switzerland: the Swiss TAVI registry.
    Wenaweser P; Stortecky S; Heg D; Tueller D; Nietlispach F; Falk V; Pedrazzini G; Jeger R; Reuthebuch O; Carrel T; Räber L; Amann FW; Ferrari E; Toggweiler S; Noble S; Roffi M; Gruenenfelder J; Jüni P; Windecker S; Huber C
    EuroIntervention; 2014 Dec; 10(8):982-9. PubMed ID: 24694729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility of the Engager™ aortic transcatheter valve system using a flexible over-the-wire design.
    Sündermann SH; Grünenfelder J; Corti R; Rastan AJ; Linke A; Lange R; Falk V; Bleiziffer S
    Eur J Cardiothorac Surg; 2012 Oct; 42(4):e48-52. PubMed ID: 22743081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Balloon Valvuloplasty Followed by Transcatheter Aortic Valve Implantation as a Staged Procedure in Patients With Low-Flow Low-Gradient Aortic Stenosis.
    Piayda K; Wimmer AC; Veulemans V; Afzal S; Sievert H; Gafoor S; Erkens R; Polzin A; Quast C; Jung C; Westenfeld R; Kelm M; Hellhammer K; Zeus T
    J Invasive Cardiol; 2018 Dec; 30(12):437-442. PubMed ID: 30504511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intermediate follow-up results from the multicenter engager European pivotal trial.
    Holzhey D; Linke A; Treede H; Baldus S; Bleiziffer S; Wagner A; Börgermann J; Scholtz W; Vanoverschelde JL; Falk V
    Ann Thorac Surg; 2013 Dec; 96(6):2095-100. PubMed ID: 24021766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: results from a propensity-matched population of the Italian OBSERVANT multicenter study.
    Onorati F; D'Errigo P; Grossi C; Barbanti M; Ranucci M; Covello DR; Rosato S; Maraschini A; Santoro G; Tamburino C; Seccareccia F; Santini F; Menicanti L;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):568-75. PubMed ID: 24263007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.